2fat: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:2fat.gif|left|200px]]
{{Seed}}
[[Image:2fat.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2fat|  PDB=2fat  |  SCENE=  }}  
{{STRUCTURE_2fat|  PDB=2fat  |  SCENE=  }}  


'''An anti-urokinase plasminogen activator receptor (UPAR) antibody: Crystal structure and binding epitope'''
===An anti-urokinase plasminogen activator receptor (UPAR) antibody: Crystal structure and binding epitope===




==Overview==
<!--  
Human urokinase-type plasminogen activator receptor (uPAR/CD87) is expressed at the invasive interface of the tumor-stromal microenvironment in many human cancers and interacts with a wide array of extracellular molecules. An anti-uPAR antibody (ATN615) was prepared using hybridoma technology. This antibody binds to uPAR in vitro with high affinity (K(d) approximately 1 nM) and does not interfere with uPA binding to uPAR. Here we report the crystal structure of the Fab fragment of ATN615 at 1.77 A and the analysis of ATN615-suPAR-ATF structure that was previously determined, emphasizing the ATN615-suPAR interaction. The complementarity determining regions (CDRs) of ATN615 consist of a high percentage of aromatic residues, and form a relatively flat and undulating surface. The ATN615 Fab fragment recognizes domain 3 of suPAR. The antibody-antigen recognition involves 11 suPAR residues and 12 Fab residues from five CDRs. Structural data suggest that Pro188, Asn190, Gly191, and Arg192 residues of uPAR are the key residues for the antibody recognition, while Pro189 and Arg192 render specificity of ATN615 for human uPAR. Interestingly, this antibody-antigen interface has a small contact area, mainly polar interaction with little hydrophobic character, yet has high binding strength. Furthermore, several solvent molecules (assigned as polyethylene glycols) were clearly visible in the binding interface between antibody and antigen, suggesting that solvent molecules may be important for the maximal binding between suPAR and ATN615 Fab. ATN615 undergoes small but noticeable changes in its CDR region upon antigen binding.
The line below this paragraph, {{ABSTRACT_PUBMED_17101149}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17101149 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17101149}}


==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Crystal structure]]
[[Category: Crystal structure]]
[[Category: Fab]]
[[Category: Fab]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 03:40:11 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 19:54:35 2008''

Revision as of 19:54, 27 July 2008

File:2fat.png

Template:STRUCTURE 2fat

An anti-urokinase plasminogen activator receptor (UPAR) antibody: Crystal structure and binding epitopeAn anti-urokinase plasminogen activator receptor (UPAR) antibody: Crystal structure and binding epitope

Template:ABSTRACT PUBMED 17101149

About this StructureAbout this Structure

2FAT is a Single protein structure of sequence from Mus musculus. Full crystallographic information is available from OCA.

ReferenceReference

An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope., Li Y, Parry G, Chen L, Callahan JA, Shaw DE, Meehan EJ, Mazar AP, Huang M, J Mol Biol. 2007 Jan 26;365(4):1117-29. Epub 2006 Oct 21. PMID:17101149

Page seeded by OCA on Sun Jul 27 19:54:35 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA